Search

Your search keyword '"Asselbergs F, W"' showing total 416 results

Search Constraints

Start Over You searched for: Author "Asselbergs F, W" Remove constraint Author: "Asselbergs F, W"
416 results on '"Asselbergs F, W"'

Search Results

2. Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning

3. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

6. The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure.

7. Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)

8. Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial

10. The plasma proteome is linked with left ventricular and left atrial function parameters in patients with chronic heart failure

11. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

13. BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

15. Influence of stressful life events and personality traits on PLN cardiomyopathy severity:an exploratory study

16. Influence of stressful life events and personality traits on PLN cardiomyopathy severity: an exploratory study

18. ONCOR: design of the Dutch cardio-oncology registry

20. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

22. A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure: Design and rationale of the MONITOR HF multicentre randomised clinical trial

23. The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy

24. Echocardiographic deformation imaging as a substitute for cardiac magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy risk prediction

33. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

34. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity:an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

35. Circadian rhythms in pump parameters of patients on contemporary left ventricular assist device support

36. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

37. Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy

38. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease

41. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

42. Dilated Cardiomyopathy – Results, Conclusions and Perspectives

44. Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

45. The effect of eplerenone on the disease onset and progression of phospholamban cardiomyopathy in presymptomatic mutation carriers: results of the i-PHORECAST trial

47. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

48. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

Catalog

Books, media, physical & digital resources